[Back]
Assoz. Prof. Mag. Dr. Verena Pichler
T: +43-1-4277-55624
Winter term 2024
270040 VO Medizinische Radiochemie 1 - Radiopharmazeutische Chemie für die nuklearmedizinische Diagnostik und Therapie
321013 PR Arzneistoffsynthese - B7 - (5 Kurse)
322026 VU Ausgewählte Kapitel aus der pharmazeutisch-chemischen Forschung - M13
323005 VO Preclinical Drug Development - MPS4
323009 PR Lab Rotation I - MPS8
323010 PR Lab Rotation II - MPS8
Summer term 2024
321013 PR Arzneistoffsynthese - B7 - (4 Kurse)
322022 VU Ausgewählte Kapitel aus der pharmazeutisch-chemischen Forschung - M13
323114 VU The path from bench to bedside - a regulatory view - MPS5
950133 VO Allgemeine und angewandte (med.) Biochemie
Winter term 2023
270015 VO Medizinische Radiochemie 1 - Radiopharmazeutische Chemie für die nuklearmedizinische Diagnostik und Therapie
321013 PR Arzneistoffsynthese - B7 - (5 Kurse)
321113 PR Arzneistoffsynthese - B7 - Zusatzkurse - (3 Kurse)
322022 VU Ausgewählte Kapitel aus der pharmazeutisch-chemischen Forschung - M13
323005 VO Preclinical Drug Development - MPS4
323009 PR Lab Rotation I - MPS8
323010 PR Lab Rotation II - MPS8
61 - 80 out of 95
Klebermass EM, Mahmudi M, Pichler V, Miller A, Vraka C, Balber T et al.. 2-[F-18]FDG: The working horse trapped in the cell's metabolic network. 2019.
Klose MHM, Theiner S, Varbanov HP, Hoefer D, Pichler V, Galanski MS et al. Development and Validation of Liquid Chromatography-Based Methods to Assess the Lipophilicity of Cytotoxic Platinum(IV) Complexes. In Contel M, editor, Unconventional Anticancer Metallodrugs and Strategies to Improve their Pharmacological Profile. 4 ed. Vol. 6. Basel: Multi-disciplinary digital publishing institute (MDPI). 2018. p. 71-84. 130. (Inorganics). doi: 10.3390/inorganics6040130
Pichler V, Zenz T, Philippe C, Vraka C, Berrotéran-Infante N, Pfaff S et al. Molar activity – The keystone in 11C-radiochemistry: An explorative study using the gas phase method. Nuclear Medicine and Biology. 2018 Dec;67:21-26. doi: 10.1016/j.nucmedbio.2018.09.003
Pichler V, Vraka C, Berroterán-Infante N, Krcal A, Eidherr H, Traub-Weidinger T et al. L-[S-methyl-C-11]methionine - An example of radiosynthetic optimization. Applied Radiation and Isotopes. 2018 Nov;141:107-111. doi: 10.1016/j.apradiso.2018.08.021
Pfaff S, Nehring T, Pichler V, Cardinale J, Mitterhauser M, Hacker M et al. Development and evaluation of a rapid analysis for HEPES determination in 68Ga-radiotracers. EJNMMI Research. 2018 Oct 23;8(1):95. doi: 10.1186/s13550-018-0449-6, 10.1186/s13550-018-0449-6
Spies M, James GM, Vraka C, Philippe C, Hienert M, Gryglewski G et al. Brain monoamine oxidase A in seasonal affective disorder and treatment with bright light therapy. Translational Psychiatry. 2018 Sept 21;8(1):198. doi: 10.1038/s41398-018-0227-2
Pichler V, Berroteran Infante N, Philippe C, Vraka C, Klebermass EM, Balber T et al. An Overview of PET Radiochemistry, Part 1: The Covalent Labels 18F, 11C, and 13N. The Journal of Nuclear Medicine. 2018 Sept 1;59(9):1350-1354. doi: 10.2967/jnumed.117.190793
Pfaff S, Philippe C, Pichler V, Hacker M, Mitterhauser M, Wadsak W. Microfluidic 68Ga-labeling: A proof of principle study. Dalton Transactions. 2018 May 7;47(17):5997-6004. doi: 10.1039/c8dt00158h
Kranz GS, Hahn A, Kraus C, Spies M, Pichler V, Jungwirth J et al. Probing the association between serotonin-1A autoreceptor binding and amygdala reactivity in healthy volunteers. NeuroImage. 2018 May 1;171:1-5. doi: 10.1016/j.neuroimage.2017.12.092
Spies M, James GM, Berroterán-Infante N, Ibeschitz H, Kranz GS, Unterholzner J et al. Assessment of Ketamine binding of the serotonin transporter in humans with positron emission tomography. International Journal of Neuropsychopharmacology. 2018 Feb;21(2):145–153. doi: 10.1093/ijnp/pyx085
Kowol C, Heffeter P, Berger W, Keppler B, Mayr J, Pichler V, inventors. MONOMALEIMIDE-FUNCTIONALIZED PLATINUM COMPOUNDS FOR CANCER THERAPY. WO2017097986 A1. 2017 Jun 15.
Goeschl S, Schreiber-Brynzak E, Pichler V, Cseh K, Heffeter P, Jungwirth U et al. Comparative studies of oxaliplatin-based platinum(IV) complexes in different in vitro and in vivo tumor models. Metallomics: integrated biometal science. 2017 Mar 22;9(3):309-322. doi: 10.1039/c6mt00226a
Hackl CM, Legina MS, Pichler V, Schmidlehner M, Roller A, Domotor O et al. Thiomaltol-Based Organometallic Complexes with 1-Methylimidazole as Leaving Group: Synthesis, Stability, and Biological Behavior. Chemistry: A European Journal. 2016 Nov 21;22(48):17269-17281. doi: 10.1002/chem.201603206
Schreiber-Brynzak E, Pichler V, Heffeter P, Hanson B, Theiner S, Lichtscheidl-Schultz I et al. Behavior of platinum(IV) complexes in models of tumor hypoxia: cytotoxicity, compound distribution and accumulation. Metallomics: integrated biometal science. 2016 Apr;8(4):422-433. doi: 10.1039/c5mt00312a
Schmidlehner M, Pichler V, Roller A, Jakupec MA, Kandioller W, Keppler BK. Organometallic complexes of (thio)allomaltol-based Mannich-products: Synthesis, stability and preliminary biological investigations. Journal of Organometallic Chemistry. 2015 Apr 15;782:69-76. doi: 10.1016/j.jorganchem.2014.10.044
Kuhn PS, Pichler V, Roller A, Hejl M, Jakupec MA, Kandioller W et al. Improved reaction conditions for the synthesis of new NKP-1339 derivatives and preliminary investigations on their anticancer potential. Dalton Transactions. 2015;44(2):659-668. doi: 10.1039/c4dt01645a
Pichler V, Goeschl S, Schreiber-Brynzak E, Jakupec MA, Galanski MS, Keppler BK. Influence of reducing agents on the cytotoxic activity of platinum(IV) complexes: induction of G(2)/M arrest, apoptosis and oxidative stress in A2780 and cisplatin resistant A2780cis cell lines. Metallomics: integrated biometal science. 2015;7(7):1078-1090. doi: 10.1039/c5mt00116a
Karnthaler-Benbakka C, Groza D, Kryeziu K, Pichler V, Roller A, Berger W et al. Tumor-Targeting of EGFR Inhibitors by Hypoxia-Mediated Activation. Angewandte Chemie (International Edition). 2014 Nov 17;53(47):12930-12935. doi: 10.1002/anie.201403936
Brynzak E, Heffeter P, Pichler V, Jakupec MA, Keppler BK. Behaviour of platinum(IV) complexes with prodrug function in different models of hypoxia. European Journal of Cancer. 2014 Nov;50:53-53.
Goeschl S, Pichler V, Brynzak E, Heffeter P, Jungwirth U, Jakupec MA et al. Platinum(IV) derivatives of oxaliplatin: Cellular effects and in vivo potency. European Journal of Cancer. 2014 Nov;50:22-22.
61 - 80 out of 95

Research Club, Accumulation of micro- and nanoplastic in colorectal cancer cells

Verena Pichler (Speaker)

13 Dec 2022

Activity: Talks and presentations › Talk or oral contribution › Science to Science

How to label micro- and nanoplastic

Verena Pichler (Speaker)

27 Sept 2022

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Lecture: Medicinal Radiochemistry

Verena Pichler (Speaker)

17 May 2022

Activity: Talks and presentations › Talk or oral contribution › Science to Science

FFG Project Spheriograph, Dynamic 3D cell culture method

Verena Pichler (Speaker)

2 May 2022

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Strategies for 18-Fluorine labelling of exendin-4

Verena Pichler (Speaker)

1 Mar 2022

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Isotopes' Availability

Verena Pichler (Speaker)

22 Oct 2021

Activity: Talks and presentations › Talk or oral contribution › Science to Science

First-in-human brain imaging of the GluN2B-containing N-methyl-D-aspartate receptor with (R)-11C-Me-NB1 PET

Lucas Rischka (Speaker), Chrysoula Vraka (Contributor), Verena Pichler (Contributor), Sazan Rasul (Contributor), Lukas Nics (Contributor), Gregor Gryglewski (Contributor), Patricia A. Handschuh (Contributor), Matej Murgaš (Contributor), G. N. Godbersen (Contributor), Leo Silberbauer (Contributor), M. Unterholzner (Contributor), C. Wotawa (Contributor), A. Haider (Contributor), H. Ahmed (Contributor), Roger Schibli (Contributor), Thomas Mindt (Contributor), Markus Mitterhauser (Contributor), Wolfgang Wadsak (Contributor), A. Hahn (Contributor), Rupert Lanzenberger (Contributor), Markus Hacker (Contributor) & Simon M. Ametamey (Contributor)

20 Oct 2021

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Imaging Probes based on Small Molecules with Emphasis on PET

Verena Pichler (Speaker)

24 Aug 2021

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Quantification of radiotracer accumulation in a dynamic column-based 3D cell culture

Verena Pichler (Speaker)

17 May 2021

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Differences and similarities between symmetrically and unsymmetrically substituted PtIV complexes with N,(N)-(di)alkylethane-1,2-diamine ligands

Verena Pichler (Speaker)

8 Sept 2013

Activity: Talks and presentations › Talk or oral contribution › Other

Department of Pharmaceutical Sciences

Strahlenschutzbeauftragte

Josef-Holaubek-Platz 2 (UZA II)
1090 Wien
Room: 2E306

T: +43-1-4277-55624

verena.pichler@univie.ac.at